For life sciences businesses, the supply chain used to mean one thing: getting products from factory or warehouse to distributors or ultimate customers as quickly and economically as possible. Now, with today’s evolving regulatory environment, an increasingly globalized market, more complex health products, and an increased focus on the patient, pharmaceutical companies and medical device manufacturers are looking at their supply chain and logistics needs in a whole new way.
The leadership of a new, marquee pharma
manufacturer approached KPMG with a paradox: It was
certainly marquee, but not new. As the highly publicized
spin-off of a global health services conglomerate, the
company began life with $18 billion in annual revenues,
an established product pipeline and instant
membership in the S&P 100. Reliant on the back-office
functions of its parent, it needed to quickly acquire the
back-office sinews of a truly stand-alone company: ERP
systems and core processes for finance, operations
and human resources.
During an intensive three-year engagement, KPMG
brought the vision of the company’s leaders to life,
working towards a target operating model through the
disciplined implementation of new systems, processes,
training and staffing. The multidisciplinary approach
eventually touched the lives of every one of the
company’s 21,000 employees, in 170 countries.
And as KPMG’s delivered tangible results, something
intangible emerged – a new company culture,
Credit Union Times is the nation's leading independent source for breaking news and analysis for credit union leaders. For more than 20 years, Credit Union Times has set the standard for editorial excellence and ethical, straight-forward reporting.